Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: The Gambler who wrote (1030)	1/18/1998 2:16:00 PM
From: jack montgomery	Read Replies (1) \| Respond to of 2173

Hi Gambler, Does anyone have any info on Inhale Therapeutic Systems? Thanks! Jack Inhale Therapeutic Systems, a small company based in Mountain View, Calif., has developed a dry, powdered insulin that can be stored at room temperature and can be inhaled rather than injected. Inhale has licensed the system to Pfizer. "We have confirmed that we can achieve levels of insulin similar to and as reproducible as those with subcutaneous injections," said George Milne, president of central research for Pfizer in New York. Pfizer hopes to file for FDA approval in 1999.